Biotech Values

[microcapfun]

>>I wonder if anyone has a list of public (I imagine private are hard to come by) companies with products in Phase 3 or beyond who don't have the resources to bring the product to market.<<

That list would probably have a significant overlap with the list of public companies with products in Phase 3 but none on the market.

I.e. pick a typical Phase 3 stage company and it is likely to be hundreds of millions of dollars away from reaching the market with its own sales force - even just its own U.S. sales force. Most Phase 3 stage companies probably don't have that much cash (example: DNDN) - and most of those that do probably have a lot of convertible debt coming due - convertible debt which (thanks to the market crash) is now very unlikely to convert into shares (example: HGSI).

micro